Application of High- and Low-resolution Mass Spectrometers Combined with Nanoscale LC and Microfluidic LC Platforms for the Quantitative Analysis of Peptide Biomarkers in Human Serum

Significance of the topic

The targeted quantitation of proteolytic peptides in human serum is essential for validating disease biomarkers in large clinical studies. High sensitivity, broad dynamic range, and reproducible analysis enable reliable detection at low attomole levels.

Objectives and study overview

This work presents a systematic comparison of eight LC-MS workflows combining two chromatographic platforms and four mass spectrometers. The aim is to assess throughput, sensitivity, linearity, and reproducibility for MRM-based quantitation of 15 stable isotope labeled and corresponding native peptides in a tryptically digested, non-depleted human serum matrix.

Methodology and instrumentation

Sample preparation involved denaturation, reduction, alkylation, tryptic digestion and detergent removal of human serum followed by spiking of SIL peptides across six orders of magnitude. Instrumentation combinations included

• Nanoscale LC: ACQUITY UPLC M-Class with Symmetry trap and HSS T3 analytical columns at 300 nL/min
• Microfluidic LC: ionKey Peptide BEH C18 device at 1 µL/min
• Mass spectrometers: Xevo TQ-S, Xevo TQ-S micro (tandem quadrupole), Xevo G2-XS QTof and SYNAPT G2-Si (quadrupole ToF)

MRM methods targeted three transitions per peptide with optimized collision energies and data acquisition settings for a minimum of 10 points across each chromatographic peak.

Main results and discussion

• Throughput: Microfluidic LC workflows halved cycle times compared to nanoscale LC (1 h vs 2 h) without loss of peak capacity.
• Sensitivity: Nanoscale LC enabled median limits of detection near 5 amol, approximately fourfold lower than microfluidic LC (median ~20 amol).
• Linearity: All configurations exhibited excellent weighted linear response (r2 ≥ 0.986) across the measured concentration range.
• Reproducibility: Tandem quadrupole systems delivered %RSD below 10% for endogenous peptide quantitation; ToF platforms showed values up to 16%.

Benefits and practical applications

The integration of microfluidic LC with a Xevo TQ-S tandem quadrupole mass spectrometer offers a balanced workflow with high throughput and robust reproducibility, well suited for large biomarker validation studies. Nanoscale LC workflows remain the choice for the lowest detection limits when sample amount is limited.

Future trends and potential applications

Advances in microfluidic device design and enhanced ion transfer optics are expected to narrow the sensitivity gap with nanoscale separations. The adoption of multiplexed MRM assays and automated platforms will further streamline large cohort studies in clinical proteomics.

Conclusion

This comparative analysis demonstrates that microfluidic LC tandem quadrupole workflows provide an optimal balance of speed and precision for peptide biomarker quantitation in serum, while nanoscale LC ToF systems deliver superior sensitivity when minimal sample amounts demand the lowest limits of detection.

References

1. Mbasu et al Advances in Quadrupole and Time of Flight Mass Spectrometry for Peptide MRM based Translational Research Analysis Proteomics in press May 23 2016 doi 10.1002/pmic.201500500